Philips Respironics, a unit of Royal Philips Electronics, has received 510(k) clearance to market its latest advancement in airway clearance technology for enhanced patient care in the hospital or in the home, the CoughAssist T70.
The new CoughAssist T70 provides an effective, comfortable alternative to traditional suctioning methods and may minimize the risk of pneumonia and infections that can lead to hospital readmissions.
According to the company, the Philips Respironics CoughAssist T70 next generation device incorporates proven technology that clears secretions from the lungs by gradually applying positive air pressure to the airway and then rapidly shifting to negative air pressure. The shift in pressure creates a high expiratory flow that simulates a deep, natural cough. Instead of introducing a suction catheter into the airway, air is delivered through a facemask, a mouthpiece, or through a simple adapter that allows the device to function with an endotracheal or tracheostomy tube, reducing discomfort and risk of infection. In addition, new design and technology updates have been developed to enhance patient and clinician use.
It features Cough-Trak, a triggering feature with automatic sensitivity that allows patients to initiate therapy and synchronize treatment with their own breathing pattern; and results, new data management software that allows patients and caregivers to monitor tidal volume, peak cough flow, and oxygen saturation levels to enhance therapy effectiveness.